| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-17 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |